City

Berlin (1)

Chicago (1)

DeSoto (1)

Garden Grove (1)

Lemon Grove (1)

Marlton (1)

Miami Lakes (1)

Richardson (1)

Torrance (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

n/a (1)

phase 1 (1)

Sponsor

Luye Pharma Group Ltd. (1)

University of California, Los Angeles (1)

Collaborator

Intervention

intranasal oxytocin (1)

invega sustenna (1)

ly03010; paliperidone palmitate (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

schizophrenia spectrum

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010; paliperidone palmitate, INVEGA SUSTENNA)

Active, not recruiting

Schizophrenia
+11 more

LY03010; paliperidone palmitate
INVEGA SUSTENNA

Garden Grove, California
+8 more

Nov 19, 2021

Schizophrenia Spectrum Trial (Intranasal Oxytocin)

Completed

Schizophrenia Spectrum

Intranasal Oxytocin

(no location specified)

Jan 11, 2019